PCRX : Summary for Pacira Pharmaceuticals, Inc. - Yahoo Finance

U.S. Markets open in 8 hrs 4 mins

Pacira Pharmaceuticals, Inc. (PCRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
46.40+1.20 (+2.65%)
At close: 4:00PM EDT
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close45.20
Bid0.00 x
Ask75.00 x 1000
Day's Range45.25 - 46.45
52 Week Range29.95 - 60.92
Avg. Volume961,382
Market Cap1.74B
PE Ratio (TTM)-45.49
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Motley Fool6 days ago

    Can Pacira Pharmaceuticals' Exparel Reduce Opioid Abuse?

    Exparel's ability to reduce post-operative pain lowers the need for opioids.

  • Motley Fool7 days ago

    Can Drugmakers Cure the Opioid Crisis?

    Deaths from prescription opioids have quadrupled since 1999, but new drugs that reduce their use may help end the opioid epidemic.

  • Capital Cube7 days ago

    Pacira Pharmaceuticals, Inc. – Value Analysis (NASDAQ:PCRX) : April 17, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Pacira Pharmaceuticals, Inc. a score of 59. Our analysis is based on comparing Pacira Pharmaceuticals, Inc. with the following peers – DURECT Corporation, Acura Pharmaceuticals, Inc., Recro Pharma, Inc., Heron Therapeutics Inc, Depomed, Inc., Cara Therapeutics Inc, Flexion Therapeutics, Inc., Cumberland Pharmaceuticals Inc., BioDelivery Sciences International, Inc. ... Read more (Read more...)